CME GroupCMEEarnings & Financial Report
CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...
Revenue
$1.5B
Gross Profit
N/A
Operating Profit
$972.6M
Net Profit
$908.0M
Gross Margin
N/A
Operating Margin
63.3%
Net Margin
59.1%
YoY Growth
-3.0%
EPS
$2.49
CME Group Q3 FY2025 Financial Summary
CME Group reported revenue of $1.5B (down 3.0% YoY) for Q3 FY2025, with a net profit of $908.0M (down 0.5% YoY) (59.1% margin).
Key Financial Metrics
| Total Revenue | $1.5B |
|---|---|
| Net Profit | $908.0M |
| Gross Margin | N/A |
| Operating Margin | 63.3% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
CME Group Q3 FY2025 revenue of $1.5B breaks down across 4 segments, led by Clearingandtransactionfees at $1.2B (79.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Clearingandtransactionfees | $1.2B | 79.9% |
| Market Data | $202.5M | 13.2% |
| Other Revenue | $107.2M | 7.0% |
| Onetimechargesandmiscellaneousrevenues | $5.2M | 0.3% |
CME Group Revenue by Segment — Quarterly Trend
CME Group revenue by segment across the last 4 reported quarters, showing how each business line (such as Clearingandtransactionfees and Market Data) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Clearingandtransactionfees | — | $1.3B | $1.2B | $1.4B |
| Market Data | — | $208.0M | $202.5M | $198.1M |
| Other Revenue | — | $112.8M | $107.2M | $105.9M |
| Onetimechargesandmiscellaneousrevenues | — | $5.9M | $5.2M | $5.6M |
CME Group Annual Revenue by Year
CME Group annual revenue history includes year-by-year totals (for example, 2025 revenue was $6.5B).
| Year | Annual Revenue |
|---|---|
| 2025 | $6.5B |
| 2024 | $6.1B |
| 2023 | $5.6B |
| 2022 | $5.0B |
CME Group Quarterly Revenue & Net Profit History
CME Group results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.9B | +14.5% | $1.2M | 0.1% |
| Q4 FY2025 | $1.6B | +8.1% | $1.2B | 71.7% |
| Q3 FY2025 | $1.5B | -3.0% | $908.0M | 59.1% |
| Q2 FY2025 | $1.7B | +10.4% | $1.0B | 60.6% |
| Q1 FY2025 | $1.6B | +10.4% | $956.2M | 58.2% |
| Q4 FY2024 | $1.5B | +6.0% | $874.6M | 57.3% |
| Q3 FY2024 | $1.6B | +18.4% | $912.8M | 57.6% |
| Q2 FY2024 | $1.5B | +12.7% | $883.2M | 57.6% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.53B | $1.58B | $1.53B | $1.64B | $1.69B | $1.54B | $1.65B | $1.88B |
| YoY Growth | 12.7% | 18.4% | 6.0% | 10.4% | 10.4% | -3.0% | 8.1% | 14.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $123.38B | $137.80B | $137.45B | $157.83B | $179.91B | $187.14B | $198.42B | $201.99B |
| Liabilities | $95.74B | $109.58B | $110.96B | $130.80B | $152.17B | $158.95B | $169.70B | $175.38B |
| Equity | $27.64B | $28.22B | $26.49B | $27.03B | $27.74B | $28.19B | $28.73B | N/A |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $776.9M | $1.00B | $1.02B | $1.12B | $1.06B | $968.1M | $1.13B |